In-depth focus

Formulation In-Depth Focus 2023

This in-depth focus features articles on trends in capsule formulation and the evolving role of titanium dioxide in formulation.

  • Trends in capsule formulation
    In this Q&A, Recipharm’s Torkel Gren discusses developments in capsule formulation, including the shift away from gelatine and the potential for growth in the inhalation capsule market.
  • Titanium dioxide: are there alternatives?
    Mike Tobyn from Bristol Myers Squibb, Jonathan Kaye from GSK, David Harris from MSD and Eli Lilly’s Jason Melnick discuss the role of E171 (titanium dioxide) in the identification of solid oral dosage forms.